The Patent Trial and Appeal Board determined that challenged claims of ST Reproductive Technologies LLC’s patent that relates to an animal monitoring device configured as a bolus are unpatentable as anticipated by and obvious over prior art, in an inter partes review by smaXtec Inc. and smaXtec Animal Care GmbH. According to the board, the challenged claims are anticipated by and obvious over various combinations of prior art, including prior art that relates to a bolus for monitoring a health condition of an animal, to a livestock management system, and to an animal monitoring device configured as a bolus for ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.